STOCK TITAN

[Form 4] ARGAN INC Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

William F. Leimkuhler, a director of Argan Inc. (AGX), reported a sale of the issuer's common stock on October 1, 2025. The filing records a sale transaction with an average price of $274.73 per share and indicates the disposal of either 11,802 shares (table entry) or 11,806 shares (explanatory paragraph), with a reported remaining beneficial ownership of 38,834 shares following the transaction. The Form 4 is a routine Section 16 disclosure showing an open-market sale by an insider and lists the reporting persons Darien, CT address and role as a director. The filing does not include any option or derivative transactions.

William F. Leimkuhler, direttore di Argan Inc. (AGX), ha riferito una vendita delle azioni ordinarie dell'emittente il 1 ottobre 2025. La segnalazione registra una vendita a prezzo medio di $274.73 per azione e indica la cessione di 11,802 azioni (voce di tabella) oppure 11,806 azioni (paragrafo esplicativo), con una proprietà beneficiaria residua riportata di 38,834 azioni dopo l'operazione. Il modulo 4 è una consueta divulgazione della Sezione 16 che mostra una vendita sul mercato da parte di un insider e indica l'indirizzo di Darien, CT e il ruolo di direttore del soggetto che segnala. La segnalazione non comprende transazioni su opzioni o derivati.

William F. Leimkuhler, director de Argan Inc. (AGX), informó de una venta de las acciones ordinarias del emisor el 1 de octubre de 2025. La presentación registra una transacción de venta a un precio medio de $274.73 por acción e indica la disposición de 11,802 acciones (entrada de la tabla) o 11,806 acciones (párrafo explicativo), con una propiedad beneficiosa restante reportada de 38,834 acciones tras la operación. El Formulario 4 es una divulgación rutinaria de la Sección 16 que muestra una venta en el mercado por parte de un insider y señala la dirección del informante en Darien, CT y su función como director. La presentación no incluye transacciones de opciones o derivados.

William F. Leimkuhler는 Argan Inc. (AGX)의 이사로서 2025년 10월 1일에 발행사의 보통주 매도를 보고했습니다. 서류에는 주당 평균가 $274.73의 매도 거래가 기록되며, 11,802주(표의 항목) 또는 11,806주(설명 단락) 중 하나의 매도가 표시되고, 거래 후 남아 있는 유향 소유 주식 수가 38,834주로 보고된다고 명시되어 있습니다. Form 4는 내부자의 공개시장 매도를 보여주는 일반적인 Section 16 공시이며, 보고자 Darien, CT 주소와 이사 직책을 나열합니다. 이 신고에는 옵션이나 파생상품 거래가 포함되지 않습니다.

William F. Leimkuhler, administrateur de Argan Inc. (AGX), a signalé la vente d'actions ordinaires de l'émetteur le 1er octobre 2025. Le dépôt enregistre une transaction de vente à un prix moyen de $274.73 par action et indique la cession soit de 11,802 actions (entrée du tableau) soit de 11,806 actions (paragraphe explicatif), avec une détention bénéficiaire restante déclarée de 38,834 actions après la transaction. Le Formulaire 4 est une divulgation routinière de la Section 16 montrant une vente sur le marché par un initié et indique l'adresse du déclarant à Darien, CT et son rôle de directeur. Le dépôt ne comprend pas de transactions d'options ou de dérivés.

William F. Leimkuhler, Direktor von Argan Inc. (AGX), meldete am 1. Oktober 2025 einen Verkauf der Stammaktien des Emittenten. Die Einreichung verzeichnet eine Verkaufs-Transaktion zum Durchschnittspreis von $274.73 pro Aktie und gibt den Abgang von entweder 11,802 Aktien (Tabelleneintrag) oder 11,806 Aktien (Erklärungstext) an, mit einem verbleibenden Nutzungswert von 38,834 Aktien nach der Transaktion. Das Formular 4 ist eine routinemäßige Offenlegung gemäß Section 16, die einen Open-Market-Verkauf eines Insiders zeigt, und listet die Adresse des Meldenden in Darien, CT und seine Rolle als Direktor auf. Die Einreichung enthält keine Optionen- oder Derivategeschäfte.

لدى وليام ف. ليـمكوْهلر، مدير في Argan Inc. (AGX)، تقرير عن بيع لأسهم الشركة العادية في 1 أكتوبر 2025. تسجل الإيداع صفقة بيع بسعر متوسط قدره $274.73 للسهم وتشير إلى التصرف في 11,802 سهمًا (إدخال الجدول) أو 11,806 أسهم (فقرة تفسيرية)، مع وجود ملكية مستفيدة متبقية تبلغ 38,834 سهمًا بعد الصفقة. النموذج 4 هو إفصاح روتيني وفق القسم 16 يظهر بيعًا في السوق المفتوحة من قبل مطلع داخلي ويسرد عنوان المبلغ عنه في دارين، كونيكتيكت ودوره كـ مدير. لا تتضمن الإيداع أي معاملات خيارات أو مشتقات.

William F. Leimkuhler,Argan Inc.(AGX)的董事,报告于2025年10月1日出售发行人的普通股。 备案记录显示以每股平均价格$274.73的出售交易,并指示出售11,802股(表格条目)或11,806股(说明段落),交易后报告的剩余受益所有权为38,834股。表格4是常规的第16条披露,显示内幕人士在公开市场上的出售,并列出申报人的达里恩,康涅狄格州地址及其董事职务。备案不包含任何期权或衍生品交易。

Positive
  • None.
Negative
  • Insider sale disclosed: The director sold shares on the open market, which may be interpreted by some investors as a negative signal even though Form 4 does not explain motivation.
  • Discrepancy in reported share count: The table lists 11,802 shares sold while the explanatory text states 11,806, creating an inconsistency in the filing that should be corrected.

Insights

TL;DR: Insider sale reported; transaction size and remaining ownership disclosed, but a small inconsistency in share count appears.

The filing documents an open-market sale by Director William F. Leimkuhler on October 1, 2025, showing an average sale price of $274.73 per share. The table reports 11,802 shares sold while the explanation states 11,806 shares, creating a discrepancy that should be resolved by an amended filing for precise record-keeping. The report shows the director retained 38,834 shares after the sale. This is a standard Section 16 disclosure; absent other context in this Form 4, the sale alone does not provide information about company performance or strategy.

TL;DR: Routine insider disposition disclosed; governance implications limited but paperwork inconsistency noted.

The Form 4 indicates the reporting person is a director and filed as an individual reporting person. The document properly records the open-market sale and remaining beneficial ownership. Governance best practices favor clarity in official filings; the conflicting share counts (11,802 vs 11,806) should be clarified by the reporting person or issuer to maintain disclosure accuracy. No derivative or related-party transactions are reported here.

William F. Leimkuhler, direttore di Argan Inc. (AGX), ha riferito una vendita delle azioni ordinarie dell'emittente il 1 ottobre 2025. La segnalazione registra una vendita a prezzo medio di $274.73 per azione e indica la cessione di 11,802 azioni (voce di tabella) oppure 11,806 azioni (paragrafo esplicativo), con una proprietà beneficiaria residua riportata di 38,834 azioni dopo l'operazione. Il modulo 4 è una consueta divulgazione della Sezione 16 che mostra una vendita sul mercato da parte di un insider e indica l'indirizzo di Darien, CT e il ruolo di direttore del soggetto che segnala. La segnalazione non comprende transazioni su opzioni o derivati.

William F. Leimkuhler, director de Argan Inc. (AGX), informó de una venta de las acciones ordinarias del emisor el 1 de octubre de 2025. La presentación registra una transacción de venta a un precio medio de $274.73 por acción e indica la disposición de 11,802 acciones (entrada de la tabla) o 11,806 acciones (párrafo explicativo), con una propiedad beneficiosa restante reportada de 38,834 acciones tras la operación. El Formulario 4 es una divulgación rutinaria de la Sección 16 que muestra una venta en el mercado por parte de un insider y señala la dirección del informante en Darien, CT y su función como director. La presentación no incluye transacciones de opciones o derivados.

William F. Leimkuhler는 Argan Inc. (AGX)의 이사로서 2025년 10월 1일에 발행사의 보통주 매도를 보고했습니다. 서류에는 주당 평균가 $274.73의 매도 거래가 기록되며, 11,802주(표의 항목) 또는 11,806주(설명 단락) 중 하나의 매도가 표시되고, 거래 후 남아 있는 유향 소유 주식 수가 38,834주로 보고된다고 명시되어 있습니다. Form 4는 내부자의 공개시장 매도를 보여주는 일반적인 Section 16 공시이며, 보고자 Darien, CT 주소와 이사 직책을 나열합니다. 이 신고에는 옵션이나 파생상품 거래가 포함되지 않습니다.

William F. Leimkuhler, administrateur de Argan Inc. (AGX), a signalé la vente d'actions ordinaires de l'émetteur le 1er octobre 2025. Le dépôt enregistre une transaction de vente à un prix moyen de $274.73 par action et indique la cession soit de 11,802 actions (entrée du tableau) soit de 11,806 actions (paragraphe explicatif), avec une détention bénéficiaire restante déclarée de 38,834 actions après la transaction. Le Formulaire 4 est une divulgation routinière de la Section 16 montrant une vente sur le marché par un initié et indique l'adresse du déclarant à Darien, CT et son rôle de directeur. Le dépôt ne comprend pas de transactions d'options ou de dérivés.

William F. Leimkuhler, Direktor von Argan Inc. (AGX), meldete am 1. Oktober 2025 einen Verkauf der Stammaktien des Emittenten. Die Einreichung verzeichnet eine Verkaufs-Transaktion zum Durchschnittspreis von $274.73 pro Aktie und gibt den Abgang von entweder 11,802 Aktien (Tabelleneintrag) oder 11,806 Aktien (Erklärungstext) an, mit einem verbleibenden Nutzungswert von 38,834 Aktien nach der Transaktion. Das Formular 4 ist eine routinemäßige Offenlegung gemäß Section 16, die einen Open-Market-Verkauf eines Insiders zeigt, und listet die Adresse des Meldenden in Darien, CT und seine Rolle als Direktor auf. Die Einreichung enthält keine Optionen- oder Derivategeschäfte.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Leimkuhler William F.

(Last) (First) (Middle)
43 SALEM STRAITS ROAD

(Street)
DARIEN CT 06820

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 S 11,802(1) D $274.73 38,834 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On October 1, 2025, the Reporting Person sold 11,806 shares of the Issuer's common stock on the open market at an average price of $274.73 per share.
/s/ William F. Leimkuhler 10/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AGX director William F. Leimkuhler report on Form 4?

He reported an open-market sale on October 1, 2025 with an average sale price of $274.73 per share and a reported remaining ownership of 38,834 shares.

How many shares did the reporting person sell in the AGX Form 4?

The filing shows 11,802 shares sold in the transaction table and the explanation paragraph lists 11,806, so the precise number is unclear from this filing.

Does the Form 4 show any option or derivative transactions for AGX?

No. Table II for derivative securities contains no reported transactions; only a non-derivative common stock sale is reported.

Is the Form 4 filing individual or joint for AGX insider activity?

The form is filed by one reporting person, indicating an individual filing by William F. Leimkuhler.

What is William F. Leimkuhlers relationship to AGX as stated on the Form 4?

He is reported as a Director of Argan Inc.
Argan Inc

NYSE:AGX

AGX Rankings

AGX Latest News

AGX Latest SEC Filings

AGX Stock Data

3.86B
13.27M
4.48%
89.2%
5.37%
Engineering & Construction
Construction - Special Trade Contractors
Link
United States
ARLINGTON